Press Release: Biofrontera : Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update
Conference scheduled for Friday, March 21, 2025 at 10:00 a.m. Eastern time
Read full article »
CEO
Hermann Luebbert
Biofrontera is a Germany-based biopharmaceutical company that develops and commercializes dermatological drugs and medical cosmetics for the treatment of skin diseases.
Read more